French private investment firm Ardian has completed the acquisition of the entire share capital of Verne, a data centre platform headquartered in the UK and diversified across Northern Europe, from investment trust Digital 9 Infrastructure, in a deal worth up to £450m.
Global law firm Taylor Wessing has appointed Shervin Shameli as Partner within its London private equity and fund formation team. Shameli joins from Reed Smith, where he was Co-Head of its private funds formation group in London.
Sustainable Development Capital has appointed Philip Doyle, a 20-year energy transition and infrastructure investment industry veteran, as Co-Fund Manager of the Green Energy Solutions Fund and Managing Director of its Dublin office.
Global buyout firm KKR & Co has agreed a public takeover of German renewable energy company Encavis, valuing the company at €2.8bn, according to a report by Reuters. Elbe Bidco, an investment vehicle owned by KKR, has offered €17.50 per share.
Renewable energy infrastructure investor Excelsior Energy Capital has sold a portfolio of 38 solar energy and solar plus storage projects from its Excelsior Renewable Energy Investment Fund I portfolio to BlackRock’s Evergreen Infrastructure Partners Fund.
Sagard, a global multi-strategy alternative investment fund with over $25bn in AUM across venture capital, private equity, private credit, real estate and royalties, is to acquire a 40% stake in US-based CLO manager HalseyPoint.
Goldman Sachs Asset Management and Sixth Street Partners are leading a $655m debt financing package deal for global alternative investment firm HIG Capital to fund a potential purchase of mechanical and industrial cleaning company USA DeBusk, according to a report by Bloomberg.
Investment platform Corinthia Global Management is hiring a 20-plus private credit team from $381m global investment management firm Barings, according to a report by Bloomberg citing people with knowledge of the matter.
Paris-based private equity firm Andera Partners has agreed to sell its portfolio company, Amolyt Pharma, a global biopharmaceutical company specialising in developing therapeutic peptides for rare endocrine and related diseases, to British-Swedish multinational pharma AstraZeneca, in a deal worth up to $1.05bn.
KSL Capital Partners, a private investment firm focused on travel and leisure businesses, has closed its latest travel and leisure focused private equity fund, KSL Capital Partners VI, with total capital commitments of $2bn.
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
